Notice of Meeting of the Advisory Council on Blood Stem Cell Transplantation, 2265 [E8-366]

Download as PDF Federal Register / Vol. 73, No. 9 / Monday, January 14, 2008 / Notices the docket name, docket identification number, agency, date of issuance, document title, document identification (ID) number, type of documents, etc. Each data field in the advance search may be searched independently or in combination with other fields, as desired. Each search yields a simultaneous display of all available information found in FDMS that is relevant to the requested subject or topic. D. How Can I Post Comments/ Submissions to FDMS? The public may post comments/ submissions online to FDMS on the Internet at https://www.Regulations.gov when a particular docket is open for public comment/submissions. For each Docket, FDA will issue a Federal Register notice or other document that provides information and instructions on posting comments/submissions to FDMS. II. Migration from the Division of Dockets Management (DDM) to FDMS A. Phased Migration Using a phased approach, all dockets currently managed by FDA’s DDM will be moved to FDMS. After the migration, the public will be able to access FDA Dockets at Regulations.gov. On this Web site, the public will be able to read background dockets, public comments the agency has received, etc. Due to the tremendous amount of data to be transferred from FDA’s DDM to FDMS, the migration will occur over the next few months. Until a Docket is migrated, the public will continue to be able to access it through FDA’s Web Site at https://www.fda.gov/ohrms/dockets. B. Docket ID Numbers Any Docket created after January 15, 2008, will receive a docket ID established by FDMS. Any Docket created on or before January 15, 2008, and migrated to FDMS will receive a docket ID established by FDMS, but it will also include a reference to its original docket (identification) number that had been assigned by FDA (legacy numbers). rmajette on PROD1PC64 with NOTICES III. Additional Information Additional details about FDMS, as well as detailed instructions and assistance for using the system, are available at https://www.Regulations.gov. Dated: January 8, 2008. Jeffrey Shuren, Assistant Commissioner for Policy. [FR Doc. E8–428 Filed 1–11–08; 8:45 am] BILLING CODE 4160–01–S VerDate Aug<31>2005 15:22 Jan 11, 2008 Jkt 214001 DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Notice of Meeting of the Advisory Council on Blood Stem Cell Transplantation Health Resources and Services Administration, HHS. ACTION: Notice of meeting of the Advisory Council on Blood Stem Cell Transplantation. AGENCY: SUMMARY: Pursuant to Public Law 92– 463, the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the first meeting of the Advisory Council on Blood Stem Cell Transplantation (ACBSCT), Department of Health and Human Services (HHS). The meeting will be held from approximately 9 a.m. to 5:30 p.m. on January 28, 2008, and from 9 a.m. to 5 p.m. on January 29, 2008, at the Hilton Washington DC/ Rockville Executive Meeting Center, 1750 Rockville Pike, MD 20852. The meeting will be open to the public; however, seating is limited and preregistration is encouraged (see below). SUPPLEMENTARY INFORMATION: Pursuant to Public Law 109–129, 42 U.S.C. 274k (section 379 of the Public Health Service Act, as amended) the ACBSCT was established to advise the Secretary of HHS and the Administrator, HRSA, on matters related to the activities of the C.W. Bill Young Cell Transplantation Program (Program) and the National Cord Blood Inventory (NCBI) Program. ACBSCT is composed of up to 25 members, including the Chair, serving as Special Government Employees. The current membership includes representatives of marrow donor centers and marrow transplant centers; representatives of cord blood banks and participating birthing hospitals; recipients of a bone marrow transplant; recipients of a cord blood transplant; persons who require such transplants; family members of such a recipient or family members of a patient who has requested the assistance of the Program in searching for an unrelated donor of bone marrow or cord blood; persons with expertise in bone marrow and cord blood transplantation; persons with expertise in typing, matching, and transplant outcome data analysis; persons with expertise in the social sciences; basic scientists with expertise in the biology of adult stem cells; ethicists; hematology and transfusion medicine researchers with expertise in adult blood stem cells; persons with PO 00000 Frm 00054 Fmt 4703 Sfmt 4703 2265 expertise in cord blood processing; and members of the general public. ACBSCT will hear presentations on and discuss cord blood bank accreditation for the NCBI Program; the Food and Drug Administration’s (FDA) Draft Guidance for Cord Blood Bank Licensure; Program confidentiality policies; Program registry size and composition; the Related Cord Blood Donor Demonstration Project; and the scientific factors that define a high quality cord blood unit. The draft meeting agenda will be available on January 15, 2008, on the HRSA’s Program Web site at https:// bloodcell.transplant.hrsa.gov/. A registration form will be available on January 7, 2008, on the HRSA’s Program Web site at https:// bloodcell.transplant.hrsa.gov/. The completed registration form should be submitted by facsimile to Professional and Scientific Associates (PSA), the logistical support contractor for the meeting, at fax number (703) 234–1701. Individuals without access to the Internet who wish to register may call Sowjanya Kotakonda with PSA at (703) 234–1737. Registration can also be completed electronically at https:// www.team-psa.com/dot/2008/acbsct/. Individuals who plan to attend the meeting and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the ACBSCT Executive Secretary, Remy Aronoff, in advance of the meeting. Mr. Aronoff may be reached by telephone at 301–443–3264, e-mail: Remy.Aronoff@hrsa.hhs.gov or in writing at the address provided below. Management and support services for ACBSCT functions are provided by the Division of Transplantation, Healthcare Systems Bureau, Health Resources and Services Administration, 5600 Fishers Lane, Parklawn Building, Room 12C–06, Rockville, Maryland 20857; telephone number 301–443–7577. After the presentations and Council discussions, members of the public will have an opportunity to provide comments. Because of the Council’s full agenda and the timeframe in which to cover the agenda topics, public comment will be limited. All public comments will be included in the record of the ACBSCT meeting. Meeting summary notes will be made available on the HRSA’s Program Web site at https://bloodcell.transplant.hrsa.gov/. Dated: January 7, 2008. Elizabeth M. Duke, Administrator. [FR Doc. E8–366 Filed 1–11–08; 8:45 am] BILLING CODE 4165–15–P E:\FR\FM\14JAN1.SGM 14JAN1

Agencies

[Federal Register Volume 73, Number 9 (Monday, January 14, 2008)]
[Notices]
[Page 2265]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-366]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


 Notice of Meeting of the Advisory Council on Blood Stem Cell 
Transplantation

AGENCY: Health Resources and Services Administration, HHS.

ACTION: Notice of meeting of the Advisory Council on Blood Stem Cell 
Transplantation.

-----------------------------------------------------------------------

SUMMARY: Pursuant to Public Law 92-463, the Federal Advisory Committee 
Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the 
first meeting of the Advisory Council on Blood Stem Cell 
Transplantation (ACBSCT), Department of Health and Human Services 
(HHS). The meeting will be held from approximately 9 a.m. to 5:30 p.m. 
on January 28, 2008, and from 9 a.m. to 5 p.m. on January 29, 2008, at 
the Hilton Washington DC/Rockville Executive Meeting Center, 1750 
Rockville Pike, MD 20852. The meeting will be open to the public; 
however, seating is limited and pre-registration is encouraged (see 
below).

SUPPLEMENTARY INFORMATION: Pursuant to Public Law 109-129, 42 U.S.C. 
274k (section 379 of the Public Health Service Act, as amended) the 
ACBSCT was established to advise the Secretary of HHS and the 
Administrator, HRSA, on matters related to the activities of the C.W. 
Bill Young Cell Transplantation Program (Program) and the National Cord 
Blood Inventory (NCBI) Program. ACBSCT is composed of up to 25 members, 
including the Chair, serving as Special Government Employees. The 
current membership includes representatives of marrow donor centers and 
marrow transplant centers; representatives of cord blood banks and 
participating birthing hospitals; recipients of a bone marrow 
transplant; recipients of a cord blood transplant; persons who require 
such transplants; family members of such a recipient or family members 
of a patient who has requested the assistance of the Program in 
searching for an unrelated donor of bone marrow or cord blood; persons 
with expertise in bone marrow and cord blood transplantation; persons 
with expertise in typing, matching, and transplant outcome data 
analysis; persons with expertise in the social sciences; basic 
scientists with expertise in the biology of adult stem cells; 
ethicists; hematology and transfusion medicine researchers with 
expertise in adult blood stem cells; persons with expertise in cord 
blood processing; and members of the general public.
    ACBSCT will hear presentations on and discuss cord blood bank 
accreditation for the NCBI Program; the Food and Drug Administration's 
(FDA) Draft Guidance for Cord Blood Bank Licensure; Program 
confidentiality policies; Program registry size and composition; the 
Related Cord Blood Donor Demonstration Project; and the scientific 
factors that define a high quality cord blood unit.
    The draft meeting agenda will be available on January 15, 2008, on 
the HRSA's Program Web site at https://bloodcell.transplant.hrsa.gov/.
    A registration form will be available on January 7, 2008, on the 
HRSA's Program Web site at https://bloodcell.transplant.hrsa.gov/. The 
completed registration form should be submitted by facsimile to 
Professional and Scientific Associates (PSA), the logistical support 
contractor for the meeting, at fax number (703) 234-1701. Individuals 
without access to the Internet who wish to register may call Sowjanya 
Kotakonda with PSA at (703) 234-1737. Registration can also be 
completed electronically at https://www.team-psa.com/dot/2008/acbsct/. 
Individuals who plan to attend the meeting and need special assistance, 
such as sign language interpretation or other reasonable 
accommodations, should notify the ACBSCT Executive Secretary, Remy 
Aronoff, in advance of the meeting. Mr. Aronoff may be reached by 
telephone at 301-443-3264, e-mail: Remy.Aronoff@hrsa.hhs.gov or in 
writing at the address provided below. Management and support services 
for ACBSCT functions are provided by the Division of Transplantation, 
Healthcare Systems Bureau, Health Resources and Services 
Administration, 5600 Fishers Lane, Parklawn Building, Room 12C-06, 
Rockville, Maryland 20857; telephone number 301-443-7577.
    After the presentations and Council discussions, members of the 
public will have an opportunity to provide comments. Because of the 
Council's full agenda and the timeframe in which to cover the agenda 
topics, public comment will be limited. All public comments will be 
included in the record of the ACBSCT meeting. Meeting summary notes 
will be made available on the HRSA's Program Web site at https://
bloodcell.transplant.hrsa.gov/.

    Dated: January 7, 2008.
Elizabeth M. Duke,
Administrator.
 [FR Doc. E8-366 Filed 1-11-08; 8:45 am]
BILLING CODE 4165-15-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.